Evidence map›Paper›PMID 31432216›Full record

ArticleIntensive care medicine2019

Determinants of the effect of extracorporeal carbon dioxide removal in the SUPERNOVA trial: implications for trial design.

Ewan C Goligher, Alain Combes, Daniel Brodie, Niall D Ferguson, Antonio M Pesenti, V Marco Ranieri, Arthur S Slutsky, SUPERNOVA investigators (European Society of Intensive Care Medicine trials group)  and for the International ECMO Network (ECMONet)

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Extracorporeal COCritical care (London, England) · 2026
    Trial
  3. Impact of draining cannula position and configuration under high-flow extracorporeal COJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. "High blood flow" versus "low blood flow" ECCOCritical care (London, England) · 2025
    Article
  11. The role of extracorporeal COFrontiers in medicine · 2025
    Review
  12. Article
  13. Expert perspectives on ECCOAnnals of intensive care · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 4 countries.

Ewan C GoligherInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada. ewan.goligher@utoronto.ca.ORCID 0000-0002-0990-6701
Alain CombesAPHP Hôpital Pitié-Salpêtrière, Institut de Cardiologie, Institute of Cardio-metabolism and Nutrition, and Service de Médecine Intensive-réanimation, UMRS_1166-ICAN, INSERM, Sorbonne Université, Paris, France.
Daniel BrodieDivision of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Niall D FergusonInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
Antonio M PesentiDipartimento di Anestesia, Rianimazione ed Emergenza Urgenza, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
V Marco RanieriPoliclinico di Sant'Orsola, Anesthesia and Intensive Care Medicine, Dipartimento di Scienze Mediche e Chirurgiche, Alma Mater Studiorum-Università di Bologna, Bologna, Italy.
Arthur S SlutskyInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
SUPERNOVA investigators (European Society of Intensive Care Medicine trials group)  and for the International ECMO Network (ECMONet)
St. Michael's Hospital · CAUniversity Health Network · CAInserm · FRFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITNewYork–Presbyterian Hospital · USUniversity of Bologna · ITUniversity of Milan · IT

Funding

CIHR AR7-162822
6 · The paper itself

Abstract

purposeTo describe the variability and determinants of the effect of extracorporeal CO

methodsUsing data from the SUPERNOVA trial (95 patients with early moderate acute respiratory distress syndrome), the independent effects of alveolar dead space fraction (ADF), respiratory system compliance (Crs), hypoxemia (PaO

resultsChanges in V

conclusionsThe lung-protective benefits of ECCO

Indexed as

Treatment OutcomeAdultAgedBlood Gas AnalysisCarbon DioxideExtracorporeal CirculationExtracorporeal Membrane OxygenationFemaleHumansLinear ModelsMaleMiddle AgedOrgan Dysfunction ScoresPilot ProjectsROC CurveSimplified Acute Physiology ScoreCarbon DioxideAcute respiratory distress syndromeArtificial ventilationExtracorporeal carbon dioxide removalPredictive enrichmentVentilator-induced lung injury

Identifiers

PMID31432216
OpenAlexW2969623083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.